Article Correctness Is Author's Responsibility: MHRP launches trial to evaluate IL-15 Agonist as therapy to reduce HIV reservoir

(The U.S. Military HIV Research Program (MHRP)) The U.S. Military HIV Research Program (MHRP) last week launched a Phase 2 clinical trial in Thailand to evaluate an interleukin-15 (IL-15) superagonist administered during acute HIV infection as an experimental therapy to target establishment of the HIV reservoir at a very early stage.